CIK 0001175680
- Non-accelerated filer
- Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753056237
- Phone
- +1 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- 4 Grant or award Chief Technology Officer acquired 12,428 shares (grant or award)
- 4 Grant or award CFO acquired 9,824 shares (grant or award)
- 4 Grant or award CMO acquired 13,849 shares (grant or award)
- 4 Grant or award CMO acquired 18,793 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 13,020 shares (grant or award)
- 4 Grant or award CFO acquired 10,292 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award President acquired 646,552 shares (grant or award)
- 4 Grant or award CMO acquired 9,457 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 8,965 shares (grant or award)
- 4 Grant or award CFO acquired 7,086 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CFO acquired 8,313 shares (grant or award)
- 4 Grant or award CMO acquired 11,094 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 10,516 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 6,588 shares (grant or award)
Page 3 of 22 · 435 filings